Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Flunixin meglumine; Florfenicol
Intervet Ireland Limited
QJ01BA99
Flunixin meglumine; Florfenicol
300/16.5 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle
amphenicols, combinations
Antibacterial
Authorised
2007-09-14
1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT RESFLOR 300/16.5 mg/mL Solution for Injection for Cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each mL contains: ACTIVE SUBSTANCES: Flunixin 16.5 mg equivalent to 27.4 mg flunixin meglumine Florfenicol 300 mg EXCIPIENTS: QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS QUANTITATIVE COMPOSITION IF THAT INFORMATION IS ESSENTIAL FOR PROPER ADMINISTRATION OF THE VETERINARY MEDICINAL PRODUC t N-Methyl-2-Pyrrolidone 250.0 mg Propylene Glycol (Antimicrobial Preservative) E1520 150.0 mg Citric acid, anhydrous Macrogol 300 Clear, light yellow to straw coloured liquid. 3. CLINICAL INFORMATION 3.1 TARGET SPECIES Cattle 3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES Treatment of respiratory infections caused by _Mannheimia haemolytica_ , _Pasteurella multocida, _ _Mycoplasma bovis _ and _Histophilus somni _ associated with pyrexia . 3.3 CONTRAINDICATIONS Do not use in adult bulls intended for breeding purposes. Do not use in animals suffering from hepatic and renal diseases. Do not use if there is a risk of gastrointestinal bleeding or in cases where there is evidence of altered hemostasis. Do not use in animals suffering from cardiac diseases. Do not use in cases of hypersensitivity to the active substances or to any of the excipients. 3.4 SPECIAL WARNINGS None . 2 3.5 SPECIAL PRECAUTIONS FOR USE Special precautions for safe use in the target species: Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. Official and local antimicrobial policies should be taken into account when the product is used.Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to florfenicol. Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of increased renal toxicity. Concurrent adm Read the complete document